Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ETC-1002 + Atorvastatin in Hyperlipidemia
NCT02659397Phase 2Completed
- Sponsor
- Esperion Therapeutics
- Start
- Dec 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bempedoic acid in hyperlipidemia, sponsored by Esperion Therapeutics. Started Dec 2015; status: completed.
02
Drugs
bempedoic acid
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT02659397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02659397.